Torii Pharmaceutical Co., Ltd. (4551.T)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Goichi Matsuda | President, CEO & Representative Director | -- | -- | 1967 |
| Yukihiro Takashima | General Manager of Finance & Accounting Department | -- | -- | -- |
| Mr. Masaki Sunami | Executive Officer, Head of Production Group & Production Group Leader | -- | -- | -- |
| Mr. Atsuyuki Kakee | Managing Executive Officer, Leader of Value Creation Group & GM of Business Development Department | -- | -- | -- |
| Mr. Katsunobu Fujiwara | Managing Executive Officer & Pharmaceutical Sales Group Leader | -- | -- | -- |
| Mr. Nobumasa Kondo | Managing Executive Officer & Planning and Support Group Leader | -- | -- | 1968 |
| Noriaki Nishino | Executive Officer, Head of Pharmacovigilance & Quality Assu Grp and Quality Assurance Grp Leader | -- | -- | -- |
Torii Pharmaceutical Co., Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 583
Description
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; CORECTIM, a topical janus kinase (JAK) inhibitor; and allergen immunotherapy tablets comprising CEDARCURE and MITICURE. In addition, it is engaged in real estate rental business. The company markets its products primarily through medical representatives for medical professionals. The company has a collaboaration with ALK-Abelló A/S to develop, market and distribute ALK's allergy immunotherapy tablet for the treatment of grass pollen allergy. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Corporate Governance
Recent Events
Recent Events Information Not Available
Upcoming Events
Jun 27, 2024
Ex-Dividend Date